Dergiler / Respiratory Case Reports / 2018 / Cilt: 7 - Sayı: 3

Changing Pulmonary Infiltrates in ABPA Misdiagnosed as Recurrent Pneumonia: A Case Report and Review of the Literature

Tekrarlayan Pnömoni Olarak Yanlış Tanı Konan ABPA Olgusunda Değişen Pulmoner İnfiltratlar: Olgu Sunumu ve Literatürün Gözden Geçirilmesi

Sayfa
134–139
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The case was eventually confirmed as ABPA, and a complete clinical and radiological response to medical treatment with antifungals and systemic corticosteroids was documented.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Pneumonia is the most common respiratory problem in tropical countries like India.
📊
Temel Bulgular & Veri:ABPA has been reported to occur in 20% of asthmatic patients admitted to hospitals and in 5% of all rhinitis cases, with varied clinical presentations.
💡
Sonuç & Katkı:The case was eventually confirmed as ABPA, and a complete clinical and radiological response to medical treatment with antifungals and systemic corticosteroids was documented.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Pneumonia is the most common respiratory problem in tropical countries like India. Allergic bronchopulmonary aspergillosis (ABPA) is routinely underdiagnosed and under evaluated as a result of clinical and radiological overlap with many other respiratory conditions, including pneumonia and tuberculosis. ABPA is the best-recognized manifestation of the fungus Aspergillus, associated with hypersensitivity to Aspergillus antigens in patients with longstanding atopic asthma. ABPA has been reported to occur in 20% of asthmatic patients admitted to hospitals and in 5% of all rhinitis cases, with varied clinical presentations. This report is a description of the case of a middle-aged male with known asthma for several years and constitutional symptoms, such as a cough, fever, and shortness of breath, who was diagnosed and treated for recurrent pneumonia. The case was eventually confirmed as ABPA, and a complete clinical and radiological response to medical treatment with antifungals and systemic corticosteroids was documented.

Abstract

Pnömoni, Hindistan gibi tropikal ülkelerde en sık görülen solunumsal problemdir. Allerjik bronkopulmoner aspergillozis (ABPA), pnömoni ve tüberküloz gibi solunumsal hastalıklar ile klinik ve radyolojik olarak karıştırıldığı için genellikle tanıda ve incelemelerde atlanmaktadır. ABPA, uzun süreli atopik astmalı hastalarda Aspergillus antijenine aşırı duyarlılık ile karakterize, aspergillus mantarına ait en iyi tanımlanmış bir tablodur. ABPA’nın hastaneye yatırılan astmatik hastaların %20’sinde ve tüm rinit olgularının %5’inde çeşitli klinik tablolarla ortaya çıktığı bildirilmiştir. Burada, öksürük, ateş, nefes darlığı gibi yakınmaları ile tekrarlayan pnömoni tanısı ile tedavi edilen, birkaç yıldır astım olduğu bilinen orta yaşlı erkek olgu sunulmuştur. Bu olguda, sonuçta ABPA olarak tanı konmuş ve sistemik steroid ve antifungal tedavi ile tam klinik ve radyolojik iyileşme sağlanmıştır.

🔖

Bu Makaleye Atıf Yap

PATIL, S., GONDHALI, G. (2018). Changing Pulmonary Infiltrates in ABPA Misdiagnosed as Recurrent Pneumonia: A Case Report and Review of the Literature. Respiratory Case Reports, Cilt: 7 - Sayı: 3, 134–139. https://ajindex.com/articles/302452

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. Agarwal R. Allergic Bronchopulmonary Aspergillosis. In: Jindal SK, Shankar PS, Raoof S, Gupta D, Aggarwal AN, Agarwal R, eds. Textbook of Pulmonary and Critical Care Medicine. 1st ed. New Delhi: Jaypee Publications; 2010:947-70
  2. Agarwal R. Allergic bronchopulmonary aspergillosis: lessons learnt from genetics. Indian J Chest Dis Allied Sci 2011; 53:137-40
  3. Muthu V, Behera D, Agarwal R. Allergic bronchopulmonary aspergillosis or pulmonary tuberculosis: a case of mistaken identity? Lung India 2015; 32:529–30. [CrossRef] 4. Tracy MC, Okorie CUA, Foley EA, Moss RB. Allergic Bronchopulmonary Aspergillosis. J Fungi (Basel) 2016; 2: pii: E17 [CrossRef] 5. Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977; 86:405–14. [CrossRef] 6. Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy 2013; 43:850–73. [CrossRef] 7. Mendelson EB, Fisher MR, Mintzer RA, Halwig JM, Greenberger PA. Roentgenographic and clinical staging of allergic bronchopulmonary aspergillosis. Chest 1985; 87:334-9. [CrossRef] 8. McCarthy DS, Simon G, Hargreave FE. The radiological appearances in allergic broncho-pulmonary aspergillosis. Clin Radiol 1970; 21:366-75. [CrossRef] 9. Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest 2006; 130:442–8
  4. Agarwal R, Aggarwal AN, Dhooria S, Singh Sehgal I, Garg M, Saikia B, et al. A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J 2016; 47:490–8. [CrossRef] 11. Moreira AS, Silva D, Ferreira AR, Delgado L. Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review. Clin Exp Allergy 2014: 44:1210–27. [CrossRef] 12. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342:756–62. [CrossRef]